Clinical trial · Observational
Identifying Molecular Drivers of Cancer
NCT02470715CI-TRIAL-00033097completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary aim of this study is to identify drivers of cancer by performing comprehensive genetic, proteomic, and metabolomic characterization of patient samples as a basis for understanding the underlying cause of disease.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Tumor | Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Molecular profile | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Molecular profile
- description
- Molecular profiled group receiving treatment based on genetics
- interventionNames
- Genetic: Molecular profile
Primary outcomes (1)
- measure
- Genetic profiling
- timeFrame
- Up to 15 years
- description
- To determine genetic changes associated with the development and growth of human disease. This should lead to better ways to detect, prevent, and treat a wide variety of human health conditions, including cancer.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnoses with cancer but healthy enough to undergo a biopsy procedure * Between the ages of 18 and 100 Exclusion Criteria: * Patients who are pregnant
References
Publications (0)
Data not yet available
No reference posted for this study.